Why TransEnterix Stock Tanked Today
Shares of TransEnterix (NYSEMKT: TRXC), an early commercial-stage robotic surgery company, ended today's trading session down another 16.4%. The company's shares have now given back a healthy 22.3% of their enormous gains following the Food and Drug Administration's (FDA) approval of its Senhance Surgical Robotic System on October 13.
Image Source: Getty Images.
This extreme volatility appears to stem from two core issues. First off, TransEnterix needs to raise capital in a big way. Turning to the specifics, the company stated during its second-quarter earnings report that it didn't have sufficient financial resources for the next 12 months -- and that bleak estimate didn't account for the enormous cost of launching the Senhance system in the United States.
Source: Fool.com
Intuitive Surgical Inc Aktie
Die Community liebt Intuitive Surgical Inc: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Trotz eines Kursziels von 397 €, das unter 412.0 € liegt, ergibt sich für Intuitive Surgical Inc ein negatives Potenzial von -3.64%.
